These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6358810)

  • 1. Glycosaminoglycans and the control of cell surface proteinase activity.
    Long WF; Williamson FB
    Med Hypotheses; 1983 Jul; 11(3):285-308. PubMed ID: 6358810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin, heparan sulfate, smooth muscle cells, and atherosclerosis.
    Karnovsky MJ; Wright TC; Castellot JJ; Choay J; Lormeau JC; Petitou M
    Ann N Y Acad Sci; 1989; 556():268-81. PubMed ID: 2525359
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates.
    Hovingh P; Piepkorn M; Linker A
    Biochem J; 1986 Jul; 237(2):573-81. PubMed ID: 2948492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of alpha 1-proteinase inhibitor and sulphated polysaccharides on the activity of m beta-acrosin.
    Long WF; Williamson FB
    Biochem Biophys Res Commun; 1983 Nov; 117(1):319-23. PubMed ID: 6229250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of heparin with myosin ATPase: possible involvement with the hemorrhagic activity and a correlation with antithrombin III high affinity-heparin molecules.
    Tersariol IL; Dietrich CP; Nader HB
    Thromb Res; 1992 Nov; 68(3):247-58. PubMed ID: 1471071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.
    Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G
    Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by heparin-modulated antithrombin III of amidolysis catalysed by m beta-acrosin.
    Long WF; Williamson FB
    Biochem J; 1984 Feb; 217(3):721-5. PubMed ID: 6231919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA
    Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effect of heparin and heparan sulphate on two abnormal antithrombin III type 3 variants.
    Fischer AM; Beguin S; Sternberg C; Dautzenberg MD
    Br J Haematol; 1987 Jun; 66(2):213-7. PubMed ID: 2955807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of heparin and related glycosaminoglycan on PDGF-induced lung fibroblast proliferation, chemotactic response and matrix metalloproteinases activity.
    Sasaki M; Kashima M; Ito T; Watanabe A; Sano M; Kagaya M; Shioya T; Miura M
    Mediators Inflamm; 2000; 9(2):85-91. PubMed ID: 10958381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of biologic properties of a polysulfated chondroitin, A73025.
    Radhakrishnamurthy B; Godofsky A; Dalferes ER; Srinivasan S; Vijayagopal P; Berenson G
    Proc Soc Exp Biol Med; 1980 Sep; 164(4):410-4. PubMed ID: 7413661
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.
    Ofosu FA; Buchanan MR; Anvari N; Smith LM; Blajchman MA
    Ann N Y Acad Sci; 1989; 556():123-31. PubMed ID: 2525356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin inhibition of insulin-like growth factor-binding protein-3 binding to human fibroblasts and rat glioma cells: role of heparan sulfate proteoglycans.
    Yang YW; Yanagishita M; Rechler MM
    Endocrinology; 1996 Oct; 137(10):4363-71. PubMed ID: 8828497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of a direct anti-factor Xa activity in certain heparin-related glycosaminoglycans.
    Larsson A; Fransson LA; Lewis WE
    Thromb Res; 1982 Jun; 26(6):401-9. PubMed ID: 7112518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulations of thrombin activity by polyelectrolytes in the presence of antithrombin III.
    Schiele J; Heuck CC
    Semin Thromb Hemost; 1991; 17 Suppl 1():35-41. PubMed ID: 2068569
    [No Abstract]   [Full Text] [Related]  

  • 16. Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2.
    Schwall RH; Chang LY; Godowski PJ; Kahn DW; Hillan KJ; Bauer KD; Zioncheck TF
    J Cell Biol; 1996 May; 133(3):709-18. PubMed ID: 8636243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin III affinity dependence on the anticoagulant, antiprotease, and tissue factor pathway inhibitor actions of heparins.
    Jeske W; Lormeau JC; Callas D; Iqbal O; Hoppensteadt D; Fareed J
    Semin Thromb Hemost; 1995; 21(2):193-200. PubMed ID: 7660142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of rat glomerular visceral epithelial cell growth by heparin.
    Adler S
    Am J Physiol; 1988 Oct; 255(4 Pt 2):F781-6. PubMed ID: 3177658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of chondrogenesis by heparan sulfate and structurally related glycosaminoglycans.
    San Antonio JD; Winston BM; Tuan RS
    Dev Biol; 1987 Sep; 123(1):17-24. PubMed ID: 2957259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of glycosaminoglycans in the regulation of T cell proliferation induced by thymic stroma-derived T cell growth factor.
    Kimura K; Matsubara H; Sogoh S; Kita Y; Sakata T; Nishitani Y; Watanabe S; Hamaoka T; Fujiwara H
    J Immunol; 1991 Apr; 146(8):2618-24. PubMed ID: 1901881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.